Market Cap 84.43M
Revenue (ttm) 0.00
Net Income (ttm) -69.68M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin 0.00%
Debt to Equity Ratio 0.00
Volume 1,454,100
Avg Vol 3,704,432
Day's Range N/A - N/A
Shares Out 56.66M
Stochastic %K 5%
Beta 2.81
Analysts Strong Sell
Price Target $13.40

Latest News on BDTX

Black Diamond Therapeutics: In Decline, But Why?

Mar 13, 2025, 3:47 PM EDT - 20 days ago

Black Diamond Therapeutics: In Decline, But Why?


Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy

Oct 12, 2023, 8:31 AM EDT - 1 year ago

Black Diamond's BDTX-1535: A Brainy Bet In Cancer Therapy


Black Diamond Therapeutics Announces CEO Transition

Sep 18, 2023, 7:00 AM EDT - 1 year ago

Black Diamond Therapeutics Announces CEO Transition